ClinTec has over 6 years of experience in the MEA region and were one of the first global CROs to enter this market with the opening of our office in Lebanon. Since then, we have opened offices in Cairo and Dubai, allowing us to provide complete coverage for the MEA region. ClinTec’s MEA teams are trained to the highest international standards and are recognised as experts in their field.

With ClinTec’s regional management team located across the MEA region, we are able to easily deal with the constant challenges associated with studies and in turn make all of our trials a success.  We understand the complexities of the clinical trial approval process and the variations within each country.

ClinTec’s vast experience in the MEA region means that we are the ideal partner for companies looking to move into this region. With the expertise of our Associate Director for Regulatory Affairs & Operations in the region, ClinTec can provide Regulatory Consultancy services for clients, having already created a regulatory binder for several MEA countries.

Our global footprint in the MEA region extends to;

Bahrain / Egypt / Jordan / Kuwait / Lebanon / Morocco / Qatar / Saudi Arabia / South Africa / Syria / Tunisia / UAE / Yemen


Why should you conduct studies in the Middle East & Africa? 

Relationships with well known and respected Key Opinion Leaders

High poverty rates mean that studies have high recruitment as patients take advantage of the medical care

High level of trust in Doctors and Investigators; for example in 2007 during the war in Lebanon, studies were not interrupted as patients continued to visit sites at the Doctors’ request

Access to highly specialised and well-trained Investigators who are fully trained in ICH-GCP and have vast experience in running clinical trials